Protalix BioTherapeutics (PLX)

Add to Watchlists
Create an Alert
4.18 -0.13  -3.02% AMEX Apr 16, 8:00PM BATS Real time Currency in USD

Protalix BioTherapeutics Total Liabilities (Quarterly):

140.28M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Protalix BioTherapeutics Total Liabilities (Quarterly) Chart

Export Data
Save Image

Protalix BioTherapeutics Historical Total Liabilities (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 140.28M
Sept. 30, 2013 137.86M
June 30, 2013 74.29M
March 31, 2013 76.22M
Dec. 31, 2012 82.08M
Sept. 30, 2012 72.61M
June 30, 2012 76.44M
March 31, 2012 74.92M
Dec. 31, 2011 77.88M
Sept. 30, 2011 78.18M
June 30, 2011 80.59M
March 31, 2011 76.22M
Dec. 31, 2010 76.05M
Sept. 30, 2010 78.69M
June 30, 2010 75.78M
March 31, 2010 80.23M
Dec. 31, 2009 82.79M
Sept. 30, 2009 8.043M
June 30, 2009 7.27M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Get data for
Advertisement

PLX Total Liabilities (Quarterly) Benchmarks

Companies
Biogen Idec 3.243B
Jazz Pharmaceuticals 942.69M
Gilead Sciences 11.13B

PLX Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 7.270M Jun 2009
Maximum 140.28M Dec 2013
Average 76.65M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.